Doheny Asset Management’s GSK GSK Stock Holding History

Doheny Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-4,960	Closed	-$258K	–	111
2015 Q2	$258K	Hold	4,960	–	–	0.12%	102
2015 Q1	$286K	Hold	4,960	–	–	0.13%	95
2014 Q4	$265K	Buy	4,960 +480	+11%	+$26.9K	0.13%	97
2014 Q3	$257K	Buy	4,480 +880	+24%	+$53.9K	0.13%	89
2014 Q2	$241K	Hold	3,600	–	–	0.11%	90
2014 Q1	$240K	Buy	3,600 +400	+13%	+$27K	0.12%	86
2013 Q4	$214K	Buy	+3,200	New	+$207K	0.11%	87

Other funds holding GSK

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Doheny Asset Management's GSK Position: Q3 2015 in Review

Doheny Asset Management sold out of GSK (GSK) in Q3 2015, closing a stake of 4,960 shares — an estimated $258K sold.

Doheny Asset Management first reported a position in GSK in Q4 2013 and held it in 7 quarters. The position peaked at $286K in Q1 2015. 706 funds tracked by Wall St. Rank hold GSK as of Q3 2015.

Doheny Asset Management reported no remaining GSK position as of Q3 2015 after selling out during the quarter.
Doheny Asset Management sold 4,960 GSK shares in Q3 2015, an estimated $258K.
Doheny Asset Management first reported a position in GSK in Q4 2013 and held it in 7 quarters.
Doheny Asset Management's GSK position peaked at $286K in Q1 2015.
706 funds tracked by Wall St. Rank held GSK as of Q3 2015.

Based on Doheny Asset Management's 13F filing for Q3 2015, filed 17 Nov 2015.